Yaso Therapeutics Incorporated
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersFate, TX
SAM.gov UEIGHMJR4AX38G9
Yaso Therapeutics develops a drug called PPCM delivered as a gel for use as a non-hormonal contraceptive and antiviral treatment. The company uses nanotechnology to create a barrier that surrounds viruses and prevents infection, and the drug shows activity against viral and bacterial pathogens including drug-resistant strains. Yaso is currently testing its platform in a Phase 1 clinical trial.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Yaso Therapeutics Incorporated | Fate | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.